Fri Apr 04 19:17:02 UTC 2025: ## CCMB Expands Sickle Cell Anemia Screening to Jharkhand

**Hyderabad, April 5, 2025** – The Centre for Cellular and Molecular Biology (CCMB) announced today the expansion of its novel molecular test for Sickle Cell Anemia (SCA) to Jharkhand. Partnering with the Tata Steel Foundation (TSF) and Jharkhand’s National Health Mission (NHM), the initiative will screen approximately two lakh people in three districts (East and West Singhbhum, and Seraikela-Kharsawan) over two years.

The project aims to leverage existing public health infrastructure for early detection and raise awareness about SCA, a genetic disorder affecting red blood cells. CCMB will train local health workers and establish a testing hub, providing counseling and prenatal diagnosis to prevent future cases. The program builds on successful preliminary testing in Telangana, with CCMB exploring similar expansions there and in Andhra Pradesh.

CCMB Director Vinay Kumar Nandicoori highlighted the institute’s role in developing the indigenous Dried Blood Spot test, repurposing existing drugs, and researching gene-editing technologies like CRISPR as potential future cures. While CRISPR technology is promising, he noted it remains years away from widespread application.

Tata Steel Foundation CEO Sourav Roy and NHM representatives emphasized the project’s significance for Jharkhand’s tribal population, outlining the logistical aspects of scaling up the program. The initiative represents a significant step toward early diagnosis and preventative measures for SCA in the region.

Read More